Geometric-Based Handwriting Intervention: Development, Feasibility and Randomized Clinical Trial
Launched by NATIONAL TAIWAN UNIVERSITY HOSPITAL · Sep 1, 2021
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special program designed to help elementary school children in Taiwan who have trouble with handwriting. The program, called the Chinese characteristic-based visual-perception motor-coordination integration program (CCVPMCI), focuses on improving skills that are important for writing in Chinese. The study aims to see if this program can help these children write better than they do now.
To be eligible for the trial, children should have handwriting performance that is poorer than their classmates as noted by their teachers. However, children with serious neurological or developmental disorders, intellectual disabilities, or problems with their muscles or senses that could affect their writing will not be included in the study. If chosen to participate, kids can expect to engage in activities aimed at improving their handwriting skills. The trial is currently recruiting participants, and it’s a great opportunity for families to support their child's handwriting development.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. poorer handwriting performance than the peers referred from teachers.
- Exclusion Criteria:
- • 1. severe neurological or pervasive developmental disorders that might directly impeded writing
- • 2. intellectual disability that might directly impeded writing
- • 3. musculoskeletal, or sensory (hearing, vision) disorders that might directly impeded writing
- • 4. difficulty in reading or expressing
About National Taiwan University Hospital
National Taiwan University Hospital (NTUH) is a leading medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a pioneer in medical education and patient care in Taiwan, NTUH integrates cutting-edge technology with comprehensive clinical expertise to facilitate groundbreaking studies across various medical fields. The hospital’s dedicated research team collaborates with local and international partners to enhance the understanding of diseases and improve treatment outcomes. By prioritizing patient safety and ethical standards, NTUH strives to contribute to the global medical community and foster advancements in healthcare practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Taipei, , Taiwan
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials